Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1077 Preclinical and IND-enabling studies of TXN10128, an ENPP1 inhibitor, for clinical evaluation in patients with solid tumor
Compose a Response to This Article
Other responses
No responses have been published for this article.